Vojta Therapy in Early Stroke Rehabilitation
Launched by CORINA EPPLE · Jan 25, 2017
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (\> 18 years)
- • CT or MRI proven acute ischemic (AIS) or hemorrhagic stroke (ICH) within 72h after onset of symptoms
- • Severe hemiparesis (medical research council scale for muscle strength ≤2)
- • premorbid modified Rankin Scale (mRS) ≤3
- • maximal National Institute of Health Stroke Scale Score (NIHSS) 25
- • Voluntary written consent by the patient
- Exclusion Criteria:
- • Severe cognitive impairment due to aphasia or dementia, prohibiting that physiotherapeutic challenges can be understood.
- • Participation on another clinical trial
- • Pregnancy
About Corina Epple
Corina Epple is a dedicated clinical trial sponsor focused on advancing medical research through innovative and rigorous study designs. With a commitment to improving patient outcomes, Epple oversees a range of clinical trials that explore novel therapies and interventions across various therapeutic areas. By fostering collaboration with healthcare professionals and leveraging cutting-edge methodologies, Corina Epple aims to contribute valuable insights to the medical community while ensuring the highest standards of ethical conduct and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frankfurt Am Main, Hessen, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials